2012
DOI: 10.1016/j.expneurol.2012.01.022
|View full text |Cite
|
Sign up to set email alerts
|

Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease

Abstract: Parkinson’s disease (PD) is characterized by a prominent degeneration of nigrostriatal dopamine (DA) neurons with an accompanying neuroinflammation. Despite clinical and preclinical studies of neuroprotective strategies for PD, there is no effective treatment for preventing or slowing the progression of neurodegeneration. The inverse correlation between caffeine consumption and risk of PD suggests that caffeine may exert neuroprotection. Whether caffeine is neuroprotective in a chronic progressive model of PD … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
74
0
3

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(81 citation statements)
references
References 37 publications
(53 reference statements)
3
74
0
3
Order By: Relevance
“…Further, Caffeine partially restored DA metabolites in rats following 6-OHDA lesions [55] and provided significant neuroprotection in MPTP models of PD. Interestingly, with caffeine intake, neuroprotection was evidenced even after the onset of neurodegeneration in rats [57].…”
Section: Common Beveragesmentioning
confidence: 98%
See 1 more Smart Citation
“…Further, Caffeine partially restored DA metabolites in rats following 6-OHDA lesions [55] and provided significant neuroprotection in MPTP models of PD. Interestingly, with caffeine intake, neuroprotection was evidenced even after the onset of neurodegeneration in rats [57].…”
Section: Common Beveragesmentioning
confidence: 98%
“…Accordingly, the ability of caffeine to down-regulate NO production, neuroinflammation, and microglial activation through these pathways are speculated to contribute to neuroprotection [56]. Recent evidence indicate that caffeine reduces dopaminergic toxicity and slows disease progression through the antagonism of adenosine vA2A receptors [57]. Hence, currently, clinical studies are underway to evaluate several lA2A receptor antagonists for symptomatic relief and slowing of disease progression [59].…”
Section: Common Beveragesmentioning
confidence: 99%
“…Protects contrary to oxidative stress and AD-like pathology in rabbit hippocampus [65]. Inhibits the loss of nigral dopaminergic neurons [66].…”
Section: Caffeinementioning
confidence: 99%
“…Table 1: Effects of caffeine on neurodegenerative disorders [59][60][61][62][63][64][65][66][67][68].…”
Section: Caffeinementioning
confidence: 99%
“…In addition, caffeine was shown to increase glutathione S-transferase activity and prevent the deterioration of red blood cells and apoptosis (11). In addition, due to being a strong assembler of hydroxyl radicals, the effects of caffeine on neurodegenerative disorders have been examined on a large scale in the last decade (12).…”
mentioning
confidence: 99%